Center Laboratories, Inc.

Taipei Exchange 4123.TWO

Center Laboratories, Inc. Price to Sales Ratio (P/S) on January 14, 2025: 20.13

Center Laboratories, Inc. Price to Sales Ratio (P/S) is 20.13 on January 14, 2025, a -7.67% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Center Laboratories, Inc. 52-week high Price to Sales Ratio (P/S) is 27.16 on July 08, 2024, which is 34.90% above the current Price to Sales Ratio (P/S).
Center Laboratories, Inc. 52-week low Price to Sales Ratio (P/S) is 19.51 on April 19, 2024, which is -3.08% below the current Price to Sales Ratio (P/S).
Center Laboratories, Inc. average Price to Sales Ratio (P/S) for the last 52 weeks is 22.31.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

Taipei Exchange: 4123.TWO

Center Laboratories, Inc.

CEO	Ms. Su-Chi Wang
IPO Date	Dec. 31, 2007
Location	Taiwan
Headquarters	No. 3-2, Yuanyuan Street
Employees	182
Sector	Health Care
Industries Pharmaceuticals

Description

Center Laboratories, Inc. engages in the manufacture and trading of various medicines in Taiwan. It engages in the research and development of small molecule drugs; manufacture and sale of pharmaceuticals; development of proteins and antibodies; and pharmaceutical CDMO, medical device, nutritional health and agribiotechnology, stem cell and immune cell therapy, and industry investment fund and venture capital businesses. The company was founded in 1959 and is headquartered in Taipei, Taiwan.

Key trends

Past 5 years